Research Analysts' Weekly Ratings Changes for Bristol-Myers Squibb


A number of firms have modified their ratings and price targets on shares of Bristol-Myers Squibb recently: 7/27/2017 - Bristol-Myers Squibb was given a new $60.00 price target on by analysts at Piper Jaffray Companies. They now have a "hold" rating on the stock.



from Biotech News